Pro Medicus Stock Fundamentals
PME Stock | 230.00 2.36 1.04% |
Pro Medicus fundamentals help investors to digest information that contributes to Pro Medicus' financial success or failures. It also enables traders to predict the movement of Pro Stock. The fundamental analysis module provides a way to measure Pro Medicus' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pro Medicus stock.
At this time, Pro Medicus' Net Income is comparatively stable compared to the past year. Income Tax Expense is likely to gain to about 35.4 M in 2024, whereas Total Operating Expenses is likely to drop slightly above 9.6 M in 2024. Pro | Select Account or Indicator |
Pro Medicus Company Return On Equity Analysis
Pro Medicus' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Pro Medicus Return On Equity | 0.51 |
Most of Pro Medicus' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pro Medicus is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition |
Pro Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Pro Medicus has a Return On Equity of 0.5072. This is much higher than that of the Health Care Technology sector and significantly higher than that of the Health Care industry. The return on equity for all Australia stocks is notably lower than that of the firm.
Pro Medicus Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Pro Medicus's current stock value. Our valuation model uses many indicators to compare Pro Medicus value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pro Medicus competition to find correlations between indicators driving Pro Medicus's intrinsic value. More Info.Pro Medicus is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.60 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Pro Medicus is roughly 1.65 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Pro Medicus' earnings, one of the primary drivers of an investment's value.Pro Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pro Medicus' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pro Medicus could also be used in its relative valuation, which is a method of valuing Pro Medicus by comparing valuation metrics of similar companies.Pro Medicus is currently under evaluation in return on equity category among its peers.
Pro Fundamentals
Return On Equity | 0.51 | ||||
Return On Asset | 0.31 | ||||
Profit Margin | 0.51 % | ||||
Operating Margin | 0.73 % | ||||
Current Valuation | 23.88 B | ||||
Shares Outstanding | 104.5 M | ||||
Shares Owned By Insiders | 51.20 % | ||||
Shares Owned By Institutions | 14.17 % | ||||
Price To Book | 128.03 X | ||||
Price To Sales | 147.79 X | ||||
Revenue | 161.5 M | ||||
Gross Profit | 126.79 M | ||||
EBITDA | 120.76 M | ||||
Net Income | 82.79 M | ||||
Total Debt | 2.07 M | ||||
Book Value Per Share | 1.80 X | ||||
Cash Flow From Operations | 86.78 M | ||||
Earnings Per Share | 0.78 X | ||||
Target Price | 152.71 | ||||
Beta | 0.54 | ||||
Market Capitalization | 23.87 B | ||||
Total Asset | 257.43 M | ||||
Retained Earnings | 173.36 M | ||||
Working Capital | 172 M | ||||
Annual Yield | 0 % | ||||
Net Asset | 257.43 M | ||||
Last Dividend Paid | 0.4 |
About Pro Medicus Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pro Medicus's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pro Medicus using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pro Medicus based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Last Reported | Projected for Next Year | ||
Current Deferred Revenue | 17.1 M | 17.9 M | |
Total Revenue | 161.5 M | 169.6 M | |
Cost Of Revenue | 39.2 M | 41.2 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Pro Stock Analysis
When running Pro Medicus' price analysis, check to measure Pro Medicus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pro Medicus is operating at the current time. Most of Pro Medicus' value examination focuses on studying past and present price action to predict the probability of Pro Medicus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pro Medicus' price. Additionally, you may evaluate how the addition of Pro Medicus to your portfolios can decrease your overall portfolio volatility.